The US Food and Drug Administration has announced the Commissioner’s National Priority Voucher (CNPV) program aimed at ...

Draig Therapeutics, a clinical-stage company based in Cardiff, UK, and aiming to transform the treatment of neuropsychiatric ...

US pharma firm Lisata Therapeutics (Nasdaq: LSTA) has teamed up with tech-bio company GATC Health in a strategic alliance ...

Japanese companies Axcelead and A2 Healthcare Corporation announced that they will enter a strategic partnership to promote ...

Japanese companies NEC Corporation and Chugai Pharmaceutical have entered a collaboration to conduct an experiment using AI ...

US biotech Dyne Therapeutics (Nasdaq: DYN) has revised its regulatory approach for DYNE-101, a treatment in development for ...

A controversial proposal to change the Inflation Reduction Act’s pricing framework for rare disease drugs has been dropped ...

A strategic partnership has been announced to develop Saudi Arabia’s first fully integrated, modular advanced therapy ...

Medicines for Europe, a manufacturers of generic and biosimilar trade group, today presented five trade policy ...

Pharma majors AbbVie and Roche were both trading lower early Tuesday after top-line results were announced from the global ...

Aquestive Therapeutics today announced that the US Food and Drug Administration (FDA) has accepted the company’s New Drug Application (NDA) for Anaphylm sublingual epinephrine film under development ...

Some 55 attorneys general (AGs), representing all eligible states and US territories, have agreed to sign on to a $7.4 ...